
Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.
www.bloomberg.com
#Bayer #Stroke #Drug #Meets #Trial #Goal #Hitting #Roadblock
Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock





